|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Deep Track Capital LP
✚
|
|
|---|---|
| CRD # | 312459 |
| SEC # | 801-120500 |
| CIK # | 0001856083 |
| AUM | $5.2 B (2025-03-31) |
| Employees | 17 (71% Investors, 0% Brokers) |
| Phone | 203-409-0810 |
| Address | 200 Greenwich Avenue Greenwich, CT 06830 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($B) |
|---|
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Guardant Health Inc | 0.2 | ||
| ISIS Pharmaceuticals Inc | 0.2 | ||
| Protagonist Therapeutics Inc | 0.2 | ||
| Dynavax Technologies Corp | 0.2 | ||
| Insmed Inc | 0.2 | ||
| Akero Therapeutics Inc | 0.2 | ||
| Health Sciences Acquisitions Corp | 0.2 | ||
| Ocular Therapeutix Inc | 0.1 | ||
| Apellis Pharmaceuticals Inc | 0.1 | ||
| Cytokinetics Inc | 0.1 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| HF | Deep Track Biotechnology Master Fund Ltd | 2021-07-08 | 5,194.3 |
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 5.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 5.2 |
| By Discretionary | ||
| Discretionary | 3 | 5.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 5.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 3.3 | |
| United States Persons | 1.9 | |
| Total | 3 | 5.2 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001856083] | |
| 3 | [0001856083] | |
| 4 | [0001856083] | |
| SC 13D | [0001856083] | |
| SC 13G | [0001856083] |
| Form 3/4/5 Subject | 2011 - 2025 |
|---|---|
| Kroin David | |
| Dynavax Technologies Corp | |
| Deep Track Biotechnology Master Fund, Ltd. | |
| Deep Track Capital, LP | |
| Nektar Therapeutics |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Caledonia US LP
✚
|
NY | 5.3 |
|
Braidwell LP
✚
|
CT | 5.2 |
|
PAAMCO Prisma LLC
✚
|
CA | 5.2 |
|
Candlestick Capital Management LP
✚
|
CT | 5.2 |
|
Hennessy Advisors Inc
✚
|
CA | 5.1 |
|
HFR Investments LLC
✚
|
IL | 5.1 |
|
HFR Asset Management LLC
✚
|
IL | 5.1 |
|
Skye Global Management LP
✚
|
FL | 5.1 |
|
Suvretta Capital Management LLC
✚
|
NY | 5.1 |
|
Polunin Capital Partners Limited
✚
|
5.1 |